Law and Economics of Personalized Medicine Institutional Levers to Foster the Translation of Personalized Medicine /

The book adds to the discussion about strategic approaches towards the translation of personalized medicine into clinical practice. It stresses the importance of non-science related, institutional barriers. A Law and Economics perspective is applied in order to examine the incentives induced by the...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής
Κύριος συγγραφέας: Bosshard, Karin (Συγγραφέας, http://id.loc.gov/vocabulary/relators/aut)
Συγγραφή απο Οργανισμό/Αρχή: SpringerLink (Online service)
Μορφή: Ηλεκτρονική πηγή Ηλ. βιβλίο
Γλώσσα:English
Έκδοση: Wiesbaden : Springer Fachmedien Wiesbaden : Imprint: Springer Gabler, 2018.
Έκδοση:1st ed. 2018.
Σειρά:Gesundheitsmanagement und Gesundheitsökonomik,
Θέματα:
Διαθέσιμο Online:Full Text via HEAL-Link
LEADER 04109nam a2200505 4500
001 978-3-658-22074-7
003 DE-He213
005 20191220125318.0
007 cr nn 008mamaa
008 180514s2018 gw | s |||| 0|eng d
020 |a 9783658220747  |9 978-3-658-22074-7 
024 7 |a 10.1007/978-3-658-22074-7  |2 doi 
040 |d GrThAP 
050 4 |a HB73 
072 7 |a LBBM  |2 bicssc 
072 7 |a LAW014000  |2 bisacsh 
072 7 |a LBBM  |2 thema 
072 7 |a LNC  |2 thema 
082 0 4 |a 330  |2 23 
100 1 |a Bosshard, Karin.  |e author.  |4 aut  |4 http://id.loc.gov/vocabulary/relators/aut 
245 1 0 |a Law and Economics of Personalized Medicine  |h [electronic resource] :  |b Institutional Levers to Foster the Translation of Personalized Medicine /  |c by Karin Bosshard. 
250 |a 1st ed. 2018. 
264 1 |a Wiesbaden :  |b Springer Fachmedien Wiesbaden :  |b Imprint: Springer Gabler,  |c 2018. 
300 |a XXXVI, 411 p. 41 illus., 7 illus. in color.  |b online resource. 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
347 |a text file  |b PDF  |2 rda 
490 1 |a Gesundheitsmanagement und Gesundheitsökonomik,  |x 2523-7667 
505 0 |a Overview of terminologies used in the context of personalized medicine -- Description of personalized medicine's impact on the healthcare landscape -- Identification and analysis of the institutional barriers to the translation of personalized medicine into clinical practice -- Analysis of institutional barriers to the translation of personalized medicine in Switzerland -- Identification and evaluation of institutional levers to foster the translation of personalized medicine into Swiss clinical practice. 
520 |a The book adds to the discussion about strategic approaches towards the translation of personalized medicine into clinical practice. It stresses the importance of non-science related, institutional barriers. A Law and Economics perspective is applied in order to examine the incentives induced by the barriers. An applied part identifies and evaluates policy levers to foster the translation of personalized medicine into Swiss clinical practice. The content • Overview of terminologies used in the context of personalized medicine • Description of personalized medicine's impact on the healthcare landscape • Identification and analysis of the institutional barriers to the translation of personalized medicine into clinical practice • Analysis of institutional barriers to the translation of personalized medicine in Switzerland • Identification and evaluation of institutional levers to foster the translation of personalized medicine into Swiss clinical practice Target groups • Social scientists with limited knowledge of personalized medicine, Law and Economics scholars, health economists • Practitioners in pharmaceutical, diagnostics and health insurance companies, healthcare policy makers and Swiss lawyers The author Dr. Karin Bosshard wrote this book during her time with a globally leading management consultancy where she was working as a strategy consultant. The author is currently working at an international pharmaceutical and diagnostics company and is a lecturer at the University of St. Gallen. 
650 0 |a Law and economics. 
650 0 |a Evolutionary economics. 
650 0 |a Health economics. 
650 1 4 |a Law and Economics.  |0 http://scigraph.springernature.com/things/product-market-codes/W39000 
650 2 4 |a Institutional/Evolutionary Economics.  |0 http://scigraph.springernature.com/things/product-market-codes/W53010 
650 2 4 |a Health Economics.  |0 http://scigraph.springernature.com/things/product-market-codes/W35000 
710 2 |a SpringerLink (Online service) 
773 0 |t Springer eBooks 
776 0 8 |i Printed edition:  |z 9783658220730 
776 0 8 |i Printed edition:  |z 9783658220754 
830 0 |a Gesundheitsmanagement und Gesundheitsökonomik,  |x 2523-7667 
856 4 0 |u https://doi.org/10.1007/978-3-658-22074-7  |z Full Text via HEAL-Link 
912 |a ZDB-2-ECF 
950 |a Economics and Finance (Springer-41170)